Impact of NOD2/CARD15 haplotypes on the outcome after kidney transplantation

Bernd Krüger1, Carsten A Böger, Bernd Schröppel

  • 1Klinik und Poliklinik für Innere Medizin II-Nephrologie, Universität Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany. bernd.krueger@klinik.uni-regensburg.de

Insights

Genetic variations in NOD2/CARD15 (nucleotide oligomerization domain-2/caspase-recruiting activating domain-15) influence mortality risk in kidney transplant recipients. Specific NOD2/CARD15 haplotypes are linked to increased all-cause and cardiovascular mortality after transplantation.

Area of Science:

  • Immunogenetics
  • Transplantation immunology
  • Innate immunity

Background:

  • Chronic allograft nephropathy and death with a functioning graft are primary causes of late kidney transplant loss.
  • NOD2/CARD15 (nucleotide oligomerization domain-2/caspase-recruiting activating domain-15), an innate immunity receptor, is implicated in inflammatory diseases and transplant mortality.
  • NOD2/CARD15 polymorphisms are associated with Crohn's disease and bone marrow transplant mortality.

Purpose of the Study:

  • To investigate the significance of NOD2/CARD15 haplotypes in kidney transplantation outcomes.
  • To determine if specific NOD2/CARD15 genetic variations impact graft survival and patient mortality.

Main Methods:

  • Genotyping of 352 first-time kidney transplant recipients for three major NOD2/CARD15 polymorphisms (R702W, G908R, 1007fs).
  • Reconstruction of NOD2/CARD15 haplotypes and stratification into diplotypes (wild type vs. mutated).
  • Statistical analysis to assess associations between NOD2/CARD15 haplotypes and clinical outcomes, including graft survival and mortality.

Main Results:

  • Four NOD2/CARD15 haplotypes were identified: CG(-) (89.8%), CGC (3.5%), CC(-) (1.6%), and TG(-) (5.1%).
  • A significant association was found between mutated NOD2/CARD15 haplotypes and increased all-cause and cardiovascular mortality, even after adjusting for covariates.
  • A univariate association was observed between mutated NOD2/CARD15 haplotypes and reduced graft survival.

Conclusions:

  • NOD2/CARD15 haplotypes demonstrate varied effects on post-transplant outcomes, particularly cardiovascular and all-cause mortality.
  • These findings suggest a role for chronic inflammation in the observed mortality risks associated with NOD2/CARD15 variations.
  • Further research is warranted to elucidate the precise association between NOD2/CARD15 haplotypes and transplant-related complications.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...